Raportit ja esitykset

10.12.2024

66^th American Society of Hematology Annual Meeting

Link to the Webcast
Link to the Poster

22.10.2024

Faron Capital Markets Day 2024

Link to the Webcast
Link to the Presentation

9.10.2024

Proactive One2One Biotech Investor Forum

Link to the Webcast

11.7.2024

FDA Feedback Update

Link to the Presentation

22.5.2024

BEXMAB Study Update

Link to the Presentation

19.3.2024

BEXMAB Study Update

Link to the Presentation

11.1.2024

J.P. Morgan Healthcare Conference

Link to the Presentation
Link to the Presented Deck

9-12.12.2023

ASH 2023 Annual Meeting

Link to the Poster

20-24.10.2023

ESMO Congress 2023

Link to the Poster

12.9.2023

H.C. Wainwright 25th Annual Global Investment Conference – September 11-13, 2023

Link to the Webcast

10.8.2023

Faron Participation at Canaccord Genuity 43rd Annual Growth Conference

Link to the Presentation

 19.7.2023

BEXMAB Study Update

Link to the Presentation

Link to the Webcast

31.5.2023

European Hematology Association Meeting 2023 – Poster

Link to the Poster

25.4.2023

Bexmarilimab for Hematological Malignancies KOL Event

Link to the Recording

3.5.2023

Faron Financial Statement 2022 Webcast

Link to the Webcast

13.12.2022

Faron as an Investment | Company Night Dec. 13, 2022

Link to the Webcast

28.11.2022

Redeye Life Science Day 2022

Link to the Q&A

Link to the Prerecorded Video

21.9.2022

Faron to Host Bexmarilimab Update Webcast

Link to the Webcast

13.9.2022

Pörssisijoittajan viikko – Faron sijoituskohteena

Toimitusjohtaja Markku Jalkasen esitys katsottavissa linkistä

12.9.2022

H.C. Wainwright 24th Annual Global Investment Conference – September 12-14, 2022

On-demand presentation is available starting Monday,
Sep 12, 2022 at 7:00 am EDT / 12:00 pm GMT / 2:00 pm EET